Speaking on applied materials, Cramer noted that he loves the quarter and opined that those who sold their stock made a mistake.
Jim Cramer, host of the famous TV show Mad Money on CNBC, has advised investors to have about five percent of their portfolio in crypto.
Cramer was quoted saying this in a list of key points from the last edition of his show where he rang the lightning round bell, a term used to refer to him providing answers to stock questions from callers at rapid speed.
He also noted that Coinbase is inexpensive while reacting to a question on the performance of Coinbase Global.
“I think Coinbase is inexpensive. I don’t really care for management because I think they let out a lot of stock when they started. I was against that. They should have been buyers, not sellers. I think the listing went very, very poorly,” added he.
He noted that the company is the natural repository of crypto. Adding that, “I will also say this, though, I own Ethereum directly. I think you should have up to 5% of your portfolio in crypto. I am a believer in crypto.”
Cramer Speaks on Crypto and Advises on Stock Options
Speaking on applied materials, Cramer noted that he loves the quarter and opined that those who sold their stock made a mistake.
In his words, “I love the quarter. Don’t be confused. Its buyable, especially with Micron rallying today. I have to tell you, I think that quarter was excellent, and people who were selling the stock actually did not know what they were doing.
Other topics he spoke on are Match Group, Royalty Pharma, and Mitek Systems.
On Match Group, he maintained that despite the general belief that the it performed poorly, the company’s quarter is not as bad as people think.
“I didn’t think the quarter was nearly as bad as the sellers said, and I think the company is really worthwhile. Maybe what we have to do is just revisit it, but I think that everything weve said about it — and weve liked it for some time — I reiterate. I like it very much, but dont forget I also like Bumble,” said he.
However, he opined that Royalty Pharma should have passed the $40 line noting that he is considering a segment of the stock.
On Mitek Systems, he stressed that even though the volume is very low, it’s still a buy.
next